Skip to main content

Lungs and breathing

Lymphangioleiomyomatosis (LAM): symptoms, diagnosis and treatment

Lymphangioleiomyomatosis, usually called LAM, is a rare, long-term, progressive lung condition that almost always occurs in females. It can cause breathlessness, collapsed lungs and kidney tumours. There is no cure, but a medicine called sirolimus can slow progression in some people. This guide explains the symptoms, how the diagnosis is made in the UK, and what living with LAM involves.

Last checked: 2026-10-10

Key facts

At a glance.

  • Rare and progressive

    Asthma + Lung UK describes LAM as a rare, long-term and progressive condition that almost always occurs in females, happening in around 3 to 8 females per million people.

  • Affects lungs, kidneys and lymphatics

    It mainly affects the lungs but can also affect the kidneys and lymphatic system, according to Asthma + Lung UK.

  • Two forms

    LAM can occur on its own (sporadic LAM) or with the inherited condition tuberous sclerosis, but most people with LAM do not have tuberous sclerosis.

  • National centre

    Nottingham University Hospitals runs the National Centre for LAM, a comprehensive clinical service for diagnosis, ongoing respiratory care and complications.

  • Treatment can slow it

    Sirolimus (rapamycin) may be given for active LAM and, if taken continuously, can slow how quickly the condition progresses.

  • Urgent warning signs

    Symptoms consistent with a collapsed lung or bleeding from a kidney tumour (angiomyolipoma) should be investigated urgently, the National Centre says.

What LAM is

Lymphangioleiomyomatosis is a rare condition that damages the lungs. Asthma + Lung UK explains that it is caused by changes in the tuberous sclerosis complex (TSC) genes, which lead to the growth of abnormal cells called LAM cells. These grow through the lungs, causing holes or cysts, blocking the airways and preventing the lungs from getting oxygen to the rest of the body.

The Nottingham National Centre for LAM describes it as a rare multi-system disease that almost exclusively affects women and that can cause progressive loss of lung function, leading to breathlessness, lung collapse and lymphatic problems in the chest and abdomen.

It is called a long-term condition because it is something you will always have, and progressive because it tends to get worse over time, though the rate varies widely between people.

Causes: sporadic LAM and tuberous sclerosis

Asthma + Lung UK says there are two ways to get LAM. It can occur on its own, called sporadic LAM, where the cause is currently unclear; sporadic LAM is not inherited and is not passed on to children. It can also occur with tuberous sclerosis, a rare inherited condition passed down from a parent. Many people with tuberous sclerosis also get LAM, but most people with LAM do not have tuberous sclerosis.

It is thought the female hormone oestrogen encourages LAM cells to grow, but it is not a direct cause. For that reason the charity says oestrogen-containing products, including contraceptive pills and hormone replacement therapy, are thought to make LAM worse, and that pregnancy may make it worse, so anyone with LAM who is pregnant or considering pregnancy should talk to their specialist team.

Symptoms

Some people with LAM have no or very mild symptoms. When symptoms occur Asthma + Lung UK lists:

  • Breathlessness, which may get worse the longer you have the condition and at the same time as your period.

  • Feeling very tired.

  • Chest pain.

  • Coughing, and sometimes coughing up blood if the lungs are affected.

  • Wheezing.

  • Stomach bloating.

Complications and urgent symptoms

LAM affects everyone differently. Asthma + Lung UK lists complications as a collapsed lung (pneumothorax), fluid around the lungs (pleural effusion), angiomyolipomas, which are kidney tumours that are usually harmless but can bleed and cause pain, and low oxygen levels, especially when exercising.

The National Centre for LAM advises people to keep a note with them in case of emergency, because many doctors in general practice and A&E will not be familiar with the disease. It says that symptoms consistent with a pneumothorax or renal bleeding should be investigated urgently. A sudden sharp chest pain with breathlessness, or sudden severe flank or abdominal pain, should lead to an emergency assessment: call 999 or go to A&E.

How LAM is diagnosed

Asthma + Lung UK says it may take some time to get a diagnosis because LAM is rare. It is usually suspected when lung cysts are seen on a CT scan, or in females with tuberous sclerosis. Because there are other causes of lung cysts, blood tests or a lung biopsy may also be needed, and an ultrasound or CT scan of the abdomen is advised.

In the UK the National Centre for LAM is at Nottingham University Hospitals. The centre provides diagnostic work-up of suspected LAM, ongoing respiratory care either at the centre or in partnership with local providers, genetic evaluation of tuberous sclerosis complex, evaluation and monitoring of kidney angiomyolipoma, surgical assessment of complications and pre-transplant evaluation. Referral comes through a clinician rather than as a self-referral, so ask your GP or respiratory specialist.

Treatment

LAM progresses at different rates and not everyone needs treatment. Asthma + Lung UK says there is currently no cure, but a medicine called rapamycin (sirolimus) may be given if you have an active case. It is an immunosuppressant medicine, and if taken continuously it can slow down how quickly the condition progresses.

Breathlessness may be managed with inhalers and pulmonary rehabilitation, and oxygen therapy may be assessed if blood oxygen levels are low, during exercise or continuously. A lung transplant may be an option for people with very severe LAM. Large or growing kidney tumours, a collapsed lung or fluid around the lungs may need additional hospital treatment.

Living with LAM

Asthma + Lung UK advises eating a regular healthy diet, keeping active, staying up to date with vaccinations including flu, COVID-19 and pneumonia, and stopping smoking if you smoke. It acknowledges that living with a long-term condition that gets worse over time can be difficult and encourages people to speak to a healthcare professional if they are struggling emotionally.

LAM Action is a UK patient charity, based in Nottingham, which supports people with LAM and their families, and their health care professionals. Asthma + Lung UK also runs a helpline and support groups for people with a lung condition.

NHS pathway or private care

LAM is managed through an NHS specialist service because of its rarity, and the National Centre for LAM works with local respiratory teams for ongoing care. A private respiratory physician can arrange CT scanning and lung function tests to investigate breathlessness or cysts, but suspected LAM would normally be referred on to the national service for confirmation and treatment decisions.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • What does LAM stand for?

    Lymphangioleiomyomatosis, usually shortened to LAM. Asthma + Lung UK describes it as a rare, long-term and progressive condition that damages the lungs and almost always occurs in females.

  • How rare is LAM?

    Asthma + Lung UK says it happens in around 3 to 8 females per million people. LAM Action says sporadic LAM affects around 10 in every million women in the UK and that around 350 women in the UK have a diagnosis, so figures differ between sources.

  • What are the symptoms of LAM?

    Breathlessness, tiredness, chest pain, coughing, wheezing and stomach bloating. Some people have no or very mild symptoms, according to Asthma + Lung UK.

  • What causes LAM?

    Changes in the tuberous sclerosis complex genes lead to abnormal LAM cells. LAM can occur alone (sporadic, not inherited) or with tuberous sclerosis, and oestrogen is thought to encourage the cells to grow.

  • How is LAM diagnosed?

    Usually after lung cysts are seen on a CT scan, with blood tests, abdominal imaging and sometimes a lung biopsy. The National Centre for LAM in Nottingham provides diagnostic work-up on referral.

  • Is there a cure?

    No. Asthma + Lung UK says there is currently no cure, but rapamycin (sirolimus) can slow progression if taken continuously, and symptoms are managed with inhalers, rehabilitation and oxygen when needed.

  • What are the emergency symptoms?

    A collapsed lung or bleeding from a kidney tumour. The National Centre for LAM says such symptoms should be investigated urgently. Call 999 or go to A&E for sudden chest pain with breathlessness.

  • Can I take hormonal contraception or HRT with LAM?

    Asthma + Lung UK says oestrogen products, including contraceptive pills and HRT, are thought to make LAM worse. Talk to your specialist team about alternatives.

  • Is pregnancy safe with LAM?

    There is a possibility that pregnancy can make LAM worse, according to Asthma + Lung UK, so speak to your specialist team before planning a pregnancy.

  • Where can I find support?

    LAM Action is a UK charity for people with LAM and their families. Asthma + Lung UK has a helpline and support groups, and the National Centre for LAM provides clinical care.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-10, next review 2027-10-10.